, Volume 14, Issue 4, pp 668–669 | Cite as

Bones, stones and androgen deprivation therapy

  • Miguel Ángel Arrabal-PoloEmail author
  • María del Carmen Cano-García
  • Miguel Arrabal-Martín
Letter to the editor


  1. 1.
    Arrabal-Polo MA, del Carmen Cano-García M, Canales BK, Arrabal-Martín M, 2014 Calcium nephrolithiasis and bone demineralization: pathophysiology, diagnosis, and medical management. Curr Opin Urol 24: 633–638.CrossRefGoogle Scholar
  2. 2.
    Letavernier E, Traxer O, Daudon M, et al, 2011 Determinants of osteopenia in male renal-stone-disease patients with idiopathic hypercalciuria. Clin J Am Soc Nephrol 6: 1149–1154.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Heilberg IP, Weisinger JR, 2006 Bone disease in idiopathic hypercalciuria. Curr Opin Nephrol Hypertens 15: 394–402.CrossRefGoogle Scholar
  4. 4.
    Allan CA, Collins VR, Frydenberg M, McLachlan RI, Matthiesson KL, 2014 Androgen deprivation therapy complications. Endocr Relat Cancer 21: T119–129.CrossRefGoogle Scholar
  5. 5.
    Nguyen PL, Alibhai SM, Basaria S, et al, 2015 Adverse Effects of Androgen Deprivation Therapy and Strategies to Mitigate Them. Eur Urol 67: 825–836.CrossRefGoogle Scholar

Copyright information

© Hellenic Endocrine Society 2015

Authors and Affiliations

  • Miguel Ángel Arrabal-Polo
    • 1
    Email author
  • María del Carmen Cano-García
    • 1
  • Miguel Arrabal-Martín
    • 2
  1. 1.Urology DepartmentLa Inmaculada HospitalAlmeríaSpain
  2. 2.Urology DepartmentUniversity Hospital of Granada, Institute IBS GranadaGranadaSpain

Personalised recommendations